Publications | Dr. Herbert Lepor
<< Return to Dr. Lepor's biosketch
Publications
| 1. | Glickman, Leonard; Godoy, Guilherme; Lepor, Herbert. "Changes in continence and erectile function between 2 and 4 years after radical prostatectomy". Journal of urology. 2009; 181: 731 (#J0157902) |
| 2. | Godoy, Guilherme; Tareen, Basir U; Lepor, Herbert. "Does benign prostatic tissue contribute to measurable PSA levels after radical prostatectomy?". Urology. 2009; 74: 167 (#J0173725) |
| 3. | Lepor H.. "Reply". BJU international. 2009; 103: 1292 (#J0165277) |
| 4. | Lepor, Herbert. "Status of radical prostatectomy in 2009: is there medical evidence to justify the robotic approach?". Reviews in urology. 2009; 11: 61 (#J0175346) |
| 5. | Marien T; Sankin A; Lepor H. "Factors Predicting Preservation of Erectile Function in Men Undergoing Open Radical Retropubic Prostatectomy". Journal of urology. 2009; 181: 1817 (#J0162287) |
| 6. | Sankin, A; Tareen, B; Lepor, H. "Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy". Prostate cancer & prostatic diseases. 2009; 12: 204 (#J0171411) |
| 7. | Tareen, Basir; Sankin, Alex; Godoy, Guilherme; Temkin, Steve; Lepor, Herbert; Taneja, Samir S. "Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohort". Urology. 2009; 73: 351 (#J0159629) |
| 8. | Tareen B; Godoy G; Sankin A; Temkin S; Lepor H; Taneja SS. "Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?". BJU international. 2009; 104: 195 (#J0161192) |
| 9. | Tareen, Basir; Godoy, Guilherme; Sankin, Alex; Temkin, Steve; Lepor, Herbert; Taneja, Samir S. "Laterality alone should not drive selection of candidates for hemi-ablative focal therapy". Journal of urology. 2009; 181: 1082 (#J0161193) |
| 10. | Lepor, Herbert; McCullough, Andrew. "Penile Rehabilitation Postprostatectomy: Is There a Role for MUSE?". Reviews in urology. 2008; 10: 1 (#J0162291) |
| 11. | Lepor, Herbert; Lepor, Norman E; Hill, Lawrence A; Trohman, Richard G. "The QT Interval and Selection of Alpha-Blockers for Benign Prostatic Hyperplasia". Reviews in urology. 2008; 10: 85 (#J0162290) |
| 12. | Lepor, Herbert; McCullough, Andrew; Engel, Jason D. "Renewing intimacy: advances in treating erectile dysfunction postprostatectomy". Reviews in urology. 2008; 10: 245 (#J0162289) |
| 13. | Lepor, Herbert; Kozirovsky, Mariana; Laze, Juliana; Telegrafi, Shpetim. "Transabdominal sonocystography: a novel technique to assess vesicourethral extravasation following radical prostatectomy". Journal of urology. 2008; 180: 2459 (#J0159414) |
| 14. | Lepor, Herbert. "Vascular targeted photodynamic therapy for localized prostate cancer". Reviews in urology. 2008; 10: 254 (#J0162288) |
| 15. | Li, Y; Li, CX; Melamed, J; Walden, P; Peng, Y; Lepor, H; Garabedian, MJ; Lee, P. "Stromal AR inhibition of prostate cancer growth and invasion by stromal AR and association with androgen independent disease". Journal of urology. 2008; 179: 187 (#J0180129) |
| 16. | Marien, Tracy P; Lepor, Herbert. "Does a nerve-sparing technique or potency affect continence after open radical retropubic prostatectomy?". BJU international. 2008; 102: 1581 (#J0156855) |
| 17. | Marien, Tracy P; Shapiro, Ellen; Melamed, Jonathan; Taouli, Bachir; Stifelman, Michael D; Lepor, Herbert. "Management of localized prostate cancer and an incidental ureteral duplication with upper pole ectopic ureter inserting into the prostatic urethra". Reviews in urology. 2008; 10: 297 (#J0161121) |
| 18. | Perlmutter, Mark A; Lepor, Herbert. "Prostate-specific antigen doubling time is a reliable predictor of imageable metastases in men with biochemical recurrence after radical retropubic prostatectomy". Urology. 2008; 71: 501 (#J0138479) |
| 19. | Sanfilippo, Nicholas J; Taneja, Samir S; Chachoua, Abraham; Lepor, Herbert; Formenti, Silvia C. "Phase I/II study of biweekly paclitaxel and radiation in androgen-ablated locally advanced prostate cancer". Journal of clinical oncology. 2008; 26: 2973 (#J0139249) |
| 20. | Tareen, B; Sankin, A; Godoy, G; Temkin, S; Lepor, H; Taneja, SS. "Comparison of pathologic and oncologic outcomes of radical retro pubic prostatectomy among men with unilateral vs. bilateral prostate cancer: Implications for focal therapy [Abstract]". European Urology Supplements. 2008; 7: 169 (#J0134580) |
| 21. | Tareen, U; Sankin, A; Temkin, S; Godoy, G; Lepor, H; Taneja, S. "Do biopsy characteristics predict unilateral prostate cancer on radical prostatectomy? [Abstract]". European Urology Supplements. 2008; 7: 252 (#J0134585) |
| 22. | Tareen, Basir; Godoy, Guilherme; Laze, Juliana; Lepor, Herbert. "Does open radical retropubic prostatectomy decrease the risk of acute urinary retention?". Urology. 2008; 72: 821 (#J0159358) |
| 23. | Huang HY; Shariat SF; Sun TT; Lepor H; Shapiro E; Hsieh JT; Ashfaq R; Lotan Y; Wu XR. "Persistent uroplakin expression in advanced urothelial carcinomas: implications in urothelial tumor progression and clinical outcome". Human pathology. 2007; 38: 1703 (#J0128410) |
| 24. | Johnson, Theodore M 2nd; Burrows, Pamela K; Kusek, John W; Nyberg, Leroy M; Tenover, J Lisa; Lepor, Herbert; Roehrborn, Claus G. "The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia". Journal of urology. 2007; 178: 2045 (#J0162294) |
| 25. | Kanofsky, Jamie A; Lepor, Herbert. "Spontaneous renal artery dissection". Reviews in urology. 2007; 9: 156 (#J0162293) |
| 26. | Lepor, Herbert. "Alpha blockers for the treatment of benign prostatic hyperplasia". Reviews in urology. 2007; 9: 181 (#J0162292) |
| 27. | Lepor, Herbert; Robbins, David. "Inguinal hernias in men undergoing open radical retropubic prostatectomy". Urology. 2007; 70: 961 (#J0132740) |
| 28. | Mo L; Zheng X; Huang HY; Shapiro E; Lepor H; Cordon-Cardo C; Sun TT; Wu XR. "Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis". Journal of clinical investigation. 2007; 117: 314 (#J0123984) |
| 29. | Sanfilippo, NJ; Taneja, SS; Chachoua, A; Lepor, H; Formenti, SC. "Phase I study of bi-weekly paclitasel and definitive radiation in androgen ablated locally advanced prostate cancer [Abstract]". International journal of radiation oncology biology physics. 2007; 69: S112 (#J0150996) |
| 30. | Slova, Denisa; Lepor, Herbert. "The short-term and long-term effects of radical prostatectomy on lower urinary tract symptoms". Journal of urology. 2007; 178: 2397 (#J0132645) |
| 31. | Fenig DM; Slova D; Lepor H. "Postoperative blood loss predicts the development of urinary extravasation on cystogram following radical retropubic prostatectomy". Journal of urology. 2006; 175: 146 (#J0112212) |
| 32. | Goto, Ken; Salm, Sarah N; Coetzee, Sandra; Xiong, Xiaozhong; Burger, Patricia E; Shapiro, Ellen; Lepor, Herbert; Moscatelli, David; Wilson, E Lynette. "Proximal prostatic stem cells are programmed to regenerate a proximal-distal ductal axis". Stem cells. 2006; 24: 1859 (#J0126282) |
| 33. | Huang G; Lepor H. "Factors predisposing to the development of anastomotic strictures in a single-surgeon series of radical retropubic prostatectomies". BJU international. 2006; 97: 255 (#J0112213) |
| 34. | Lepor, H. "Insights into the natural history and treatment of benign prostatic hyperplasia". Journal of urology. 2006; 175: 815 (#J0112016) |
| 35. | Lepor, H. "Open versus robotic radical prostatectomy". Urologic oncology. 2006; 24: 91 (#J0112795) |
| 36. | Sultan, Raymond; Slova, Denisa; Thiel, Bob; Lepor, Herbert. "Time to return to work and physical activity following open radical retropubic prostatectomy". Journal of urology. 2006; 176: 1420 (#J0121136) |
| 37. | Kaufman, JD; Lepor, H. "Reoperation versus observation in men with major bleeding after radical retropubic prostatectomy". Urology. 2005; 66: 561 (#J0106680) |
| 38. | Patel R; Lepor H; Thiel RP; Taneja SS. "Prostate-specific antigen velocity accurately predicts response to salvage radiotherapy in men with biochemical relapse after radical prostatectomy". Urology. 2005; 65: 942 (#J0103255) |
| 39. | Shen S; Lepor H; Yaffee R; Taneja SS. "Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy". Journal of urology. 2005; 173: 777 (#J0103256) |
| 40. | Twiss, C; Slova, D; Lepor, H. "Outcomes for men younger than 50 years undergoing radical prostatectomy". Urology. 2005; 66: 141 (#J0106677) |
| 41. | Xiao, Chuan-Guo; Du, Mao-Xin; Li, Bing; Liu, Zhao; Chen, Ming; Chen, Zhao-Hui; Cheng, Ping; Xue, Xiao-Nan; Shapiro, Ellen; Lepor, Herbert. "An artificial somatic-autonomic reflex pathway procedure for bladder control in children with spina bifida". Journal of urology. 2005; 173: 2112 (#J0154232) |
| 42. | Bosland, MC; Zeleniuch-Jacquotte, A; Melamed, J; Lepor, H; Taneja, SS; Schmoll, J; Watanabe, H; Levinson, B; Randolph, C; Walden, PD. ""A randomized, controlled 6-Mo intervention with soy protein isolate in men with biochemical recurrence after radical prostatectomy" [Abstract]". Journal of nutrition. 2004; 134: 1259S (#J0072616) |
| 43. | Lepor, H. "Contemporary management of prostate cancer with lethal potential - The Davis/Shaves/Schellhammer article reviewed". Oncology. 2004; 18: 829 (#J0115423) |
| 44. | Lepor H; Kaci L; Xue X. "Continence following radical retropubic prostatectomy using self-reporting instruments". Journal of urology. 2004; 171: 1212 (#J0067159) |
| 45. | Lepor H; Kaci L. "The impact of open radical retropubic prostatectomy on continence and lower urinary tract symptoms: a prospective assessment using validated self-administered outcome instruments". Journal of urology. 2004; 171: 1216 (#J0067158) |
| 46. | Lepor H. "Radical prostatectomy: status and opportunities for improving outcomes". Cancer investigation. 2004; 22: 435 (#J0071284) |
| 47. | Lepor H; Kaci L. "Role of intraoperative biopsies during radical retropubic prostatectomy". Urology. 2004; 63: 499 (#J0069821) |
| 48. | Schettino CJ; Kramer EL; Noz ME; Taneja S; Padmanabhan P; Lepor H. "Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer". American journal of roentgenology. 2004; 183: 519 (#J0068470) |
| 49. | Shapiro E; Huang H; McFadden DE; Masch RJ; Ng E; Lepor H; Wu XR. "THE PROSTATIC UTRICLE IS NOT A MULLERIAN DUCT REMNANT: IMMUNOHISTOCHEMICAL EVIDENCE FOR A DISTINCT UROGENITAL SINUS ORIGIN". Journal of urology. 2004; 172: 1753 (#J0069820) |
| 50. | Bautista OM; Kusek JW; Nyberg LM; McConnell JD; Bain RP; Miller G; Crawford ED; Kaplan SA; Sihelnik SA; Brawer MK; Lepor H. "Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial". Controlled clinical trials. 2003; 24: 224 (#J0069826) |
| 51. | Bosland, MC; Zeleniuch-Jacquotte, A; Melamed, J; Lepor, H; Taneja, SS; Schmoll, J; Watanabe, H; Levinson, B; Walden, PD. "A randomized, controlled six-month intervention study soy protein isolate in men with biochemical recurrence after radical prostatectomy [Abstract]". Cancer epidemiology biomarkers & prevention. 2003; 12: 1327S (#J0101597) |
| 52. | Hsu EI; Hong EK; Lepor H. "Influence of body weight and prostate volume on intraoperative, perioperative, and postoperative outcomes after radical retropubic prostatectomy". Urology. 2003; 61: 601 (#J0053325) |
| 53. | Johnson TM 2nd; Jones K; Williford WO; Kutner MH; Issa MM; Lepor H. "Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial". Journal of urology. 2003; 170: 145 (#J0069825) |
| 54. | Lepor H; Kaci L. "Contemporary evaluation of operative parameters and complications related to open radical retropubic prostatectomy". Urology. 2003; 62: 702 (#J0053044) |
| 55. | Lepor H. "Practical considerations in radical retropubic prostatectomy". Urologic clinics of North America. 2003; 30: 363 (#J0053278) |
| 56. | McConnell JD; Roehrborn CG; Bautista OM; Andriole GL Jr; Dixon CM; Kusek JW; Lepor H; McVary KT; Nyberg LM Jr; Clarke HS; Crawford ED; Diokno A; Foley JP; Foster HE; Jacobs SC; Kaplan SA; Kreder KJ; Lieber MM; Lucia MS; Miller GJ; Menon M; Milam DF; Ramsdell JW; Schenkman NS; Slawin KM; Smith JA. "The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia". New England journal of medicine. 2003; 349: 2387 (#J0067496) |
| 57. | Naya Y; Fritsche HA; Cheli CD; Stamey TA; Bartsch G; Brawer MK; Childs S; Taneja SS; Lepor H; Partin AW; Sokoll LJ; Chan DW; Babaian RJ. "Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer". Urology. 2003; 62: 1058 (#J0069823) |
| 58. | Nelson JB; Lepor H. "Prostate cancer: radical prostatectomy". Urologic clinics of North America. 2003; 30: 703 (#J0069822) |
| 59. | Partin AW; Brawer MK; Bartsch G; Horninger W; Taneja SS; Lepor H; Babaian R; Childs SJ; Stamey T; Fritsche HA; Sokoll L; Chan DW; Thiel RP; Cheli CD. "Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial". Journal of urology. 2003; 170: 1787 (#J0069824) |
| 60. | Patel R; Lepor H. "Removal of urinary catheter on postoperative day 3 or 4 after radical retropubic prostatectomy". Urology. 2003; 61: 156 (#J0053380) |
| 61. | Patel R; Fiske J; Lepor H. "Tamsulosin reduces the incidence of acute urinary retention following early removal of the urinary catheter after radical retropubic prostatectomy". Urology. 2003; 62: 287 (#J0053144) |
| 62. | Shah O; Robbins DA; Melamed J; Lepor H. "The New York University nerve sparing algorithm decreases the rate of positive surgical margins following radical retropubic prostatectomy". Journal of urology. 2003; 169: 2147 (#J0051301) |
| 63. | Takao T; Tsujimura A; Coetzee S; Salm SN; Lepor H; Shapiro E; Moscatelli D; Wilson EL. "Stromal/epithelial interactions of murine prostatic cell lines in vivo: a model for benign prostatic hyperplasia and the effect of doxazosin on tissue size". Prostate. 2003; 54: 17 (#J0048391) |
| 64. | Cheli, CD; Horninger, W; Babaian, R; Fritsche, H; Taneja, S; Lepor, H; Sokoll, L; Chan, D; Childs, S. "Complexed PSA for early detection of prostate cancer in men with serum PSA values of 2-4 ng/mL [Abstract]". Clinical chemistry. 2002; 48: A41 (#J0039499) |
| 65. | Horninger, Wolfgang; Cheli, Carol D; Babaian, Richard J; Fritsche, Herbert A; Lepor, Herbert; Taneja, Samir S; Childs, Stacy; Stamey, Thomas A; Sokoll, Lori J; Chan, Daniel W; Brawer, Michael K; Partin, Alan W; Bartsch, Georg. "Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter". Urology. 2002; 60: 31 (#J0119947) |
| 66. | Lefkowitz, Gary K; Taneja, Samir S; Brown, Jordan; Melamed, Jonathan; Lepor, Herbert. "Followup interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate specific antigen levels". Journal of urology. 2002; 168: 1415 (#J0119949) |
| 67. | McCullough A; Woo K; Telegrafi S; Lepor H. "Is sildenafil failure in men after radical retropubic prostatectomy (RRP) due to arterial disease? Penile duplex Doppler findings in 174 men after RRP". International journal of impotence research. 2002; 14: 462 (#J0045681) |
| 68. | Naya, Yoshio; Stamey, Thomas A; Cheli, Carol D; Partin, Alan W; Sokoll, Lori J; Chan, Daniel W; Brawer, Michael K; Taneja, Samir S; Lepor, Herbert; Bartsch, Georg; Childs, Stacy; Fritsche, Herbert A; Babaian, Richard J. "Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?". Urology. 2002; 60: 36 (#J0119946) |
| 69. | Taneja, Samir S; Hsu, Elias I; Cheli, Carol D; Walden, Paul; Bartsch, Georg; Horninger, Wolfgang; Babaian, Richard J; Fritsche, Herbert A; Childs, Stacy; Stamey, Thomas A; Sokoll, Lori J; Chan, Daniel W; Brawer, Michael K; Partin, Alan W; Lepor, Herbert. "Complexed prostate-specific antigen as a staging tool: results based on a multicenter prospective evaluation of complexed prostate-specific antigen in cancer diagnosis". Urology. 2002; 60: 10 (#J0119948) |
| 70. | Tsujimura A; Koikawa Y; Salm S; Takao T; Coetzee S; Moscatelli D; Shapiro E; Lepor H; Sun TT; Wilson EL. "Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis". Journal of cell biology. 2002; 157: 1257 (#J0044740) |
| 71. | Zhu X; Cheng J; Gao J; Lepor H; Zhang ZT; Pak J; Wu XR. "Isolation of mouse THP gene promoter and demonstration of its kidney-specific activity in transgenic mice". American journal of physiology. Renal physiology. 2002; 282: F608 (#J0054022) |
| 72. | Zhu, Xinhua; Cheng, Jin; Gao, Jing; Lepor, Herbert; Zhang, Zhong-Ting; Pak, Joanne; Wu, Xue-Ru. "Isolation of mouse THP gene promoter and demonstration of its kidney-specific activity in transgenic mice". American journal of physiology. 2002; 282: F608 (#J0170139) |
| 73. | Bosland MC; Kato I; Melamed J; Taneja S; Lepor H; Torre P; Walden P; Zeleniuch-Jacquotte A; Lumey LH. "Chemoprevention trials in men with prostate-specific antigen failure or at high risk for recurrence after radical prostatectomy: Application to efficacy assessment of soy protein". Urology. 2001; 57: 202 (#J0020360) |
| 74. | Johnson, TM; Jones, K; Williford, WO; Lepor, H; Kutner, MH. "Changes in nocturia from medical treatment of B [Abstract]". Journal of the American Geriatrics Society. 2001; 49: S137 (#J0099822) |
| 75. | Lefkowitz GK; Sidhu GS; Torre P; Lepor H; Taneja SS. "Is repeat prostate biopsy for high-grade prostatic intraepithelial neoplasia necessary after routine 12-core sampling?". Urology. 2001; 58: 999 (#J0028799) |
| 76. | Lepor, H. "Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin in men with lower urinary tract symptoms and clinical evidence of benign prostatic hyperplasia - Editorial comment". Urology. 2001; 58: 208 (#J0099457) |
| 77. | Lepor H; Nieder AM; Fraiman MC. "Early removal of urinary catheter after radical retropubic prostatectomy is both feasible and desirable". Urology. 2001; 58: 425 (#J0028877) |
| 78. | Lepor H; Nieder AM; Ferrandino MN. "Intraoperative and postoperative complications of radical retropubic prostatectomy in a consecutive series of 1,000 cases". Journal of urology. 2001; 166: 1729 (#J0028911) |
| 79. | Lepor, H. "Radical-prostatectomy - Preface". Urologic clinics of North America. 2001; 28: XV (#J0099264) |
| 80. | Lepor H. "Radical retropubic prostatectomy". Urologic clinics of North America. 2001; 28: 509 (#J0028867) |
| 81. | Marsh DW; Lepor H. "Predicting continence following radical prostatectomy". Current urology reports. 2001; 2: 248 (#J0043502) |
| 82. | Narayan, P; Lepor, H. "Long-term, open-label, phase III multicenter study of tamsulosin in benign prostatic hyperplasia". Urology. 2001; 57: 466 (#J0100080) |
| 83. | Nieder AM; Rosenblum N; Lepor H. "Comparison of two different doses of preoperative recombinant erythropoietin in men undergoing radical retropubic prostatectomy". Urology. 2001; 57: 737 (#J0023158) |
| 84. | Park R; Martin S; Goldberg JD; Lepor H. "Anastomotic strictures following radical prostatectomy: insights into incidence, effectiveness of intervention, effect on continence, and factors predisposing to occurrence". Urology. 2001; 57: 742 (#J0023157) |
| 85. | Rosenblum N; Lepor H. "Radical retropubic prostatectomy. Preoperative management". Urologic clinics of North America. 2001; 28: 499 (#J0028868) |
| 86. | Schettino, CJ; Noz, ME; Kramer, E; Taneja, S; Lepor, H. "Impact of image fusion of In-111 Capromab Pendetide with MR or CT in patients with recurrent prostate CA [Abstract]". Journal of nuclear medicine. 2001; 42: 294 (#J0046027) |
| 87. | Shah O; Melamed J; Lepor H. "Analysis of apical soft tissue margins during radical retropubic prostatectomy". Journal of urology. 2001; 165: 1943 (#J0022562) |
| 88. | Taneja SS; Tran K; Lepor H. "Volume-specific cutoffs are necessary for reproducible application of prostate-specific antigen density of the transition zone in prostate cancer detection". Urology. 2001; 58: 222 (#J0028985) |
| 89. | Walsh, PC; Marschke, P; Catalona, WJ; Lepor, H; Martin, S; Myers, RP; Steiner, MS. "Efficacy of first-generation Cavermap to verify location and function of cavernous nerves during radical prostatectomy: A multi-institutional evaluation by experienced surgeons". Urology. 2001; 57: 491 (#J0100081) |
| 90. | Barry, MJ; Williford, WO; Fowler, FJ; Jones, KM; Lepor, H. "Filling and voiding symptoms in the American Urological Association symptom index: The value of their distinction in a Veterans Affairs randomized trial of medical therapy in men with a clinical diagnosis of benign prostatic hyperplasia". Journal of urology. 2000; 164: 1559 (#J0097692) |
| 91. | Kirby R; Andersson KE; Lepor H; Steers WD. "alpha(1)-Adrenoceptor selectivity and the treatment of benign prostatic hyperplasia and lower urinary tract symptoms". Prostate cancer & prostatic diseases. 2000; 3: 76 (#J0069827) |
| 92. | Lepor H; Jones K; Williford W. "The mechanism of adverse events associated with terazosin: an analysis of the Veterans Affairs cooperative study". Journal of urology. 2000; 163: 1134 (#J0009072) |
| 93. | Lepor, Herbert. "Prostatic diseases". Philadelphia : W.B. Saunders Co., c2000. 2000; (#B0001103) |
| 94. | Rosenblum N; Levine MA; Handler T; Lepor H. "The role of preoperative epoetin alfa in men undergoing radical retropubic prostatectomy". Journal of urology. 2000; 163: 829 (#J0004784) |
| 95. | Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL. "Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines". Journal of cellular physiology. 2000; 184: 70 (#J0008940) |
| 96. | Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL. "Transforming growth factor-beta is an autocrine mitogen for a novel androgen-responsive murine prostatic smooth muscle cell line, PSMC1". Journal of cellular physiology. 2000; 185: 416 (#J0029632) |
| 97. | Twiss C; Martin S; Shore R; Lepor H. "A continence index predicts the early return of urinary continence after radical retropubic prostatectomy". Journal of urology. 2000; 164: 1241 (#J0044273) |
| 98. | Brawer, MK; Lin, DW; Williford, WO; Jones, K; Lepor, H. "Effect of finasteride and or terazosin on serum P". Prostate. 1999; 39: 234 (#J0096218) |
| 99. | Fraiman, MC; Lepor, H; McCullough, AR. "Changes in penile morphometrics in men with erectile dysfunction after nerve-sparing radical retropubic prostatectomy". Molecular urology. 1999; 3: 109 (#J0095996) |
| 100. | Hong EK; Lepor H; McCullough AR. "Time dependent patient satisfaction with sildenafil for erectile dysfunction (ED) after nerve-sparing radical retropubic prostatectomy (RRP)". International journal of impotence research. 1999; 11 Suppl 1: S15 (#J0009269) |
| 101. | Li SM; Zhang ZT; Chan S; McLenan O; Dixon C; Taneja S; Lepor H; Sun TT; Wu XR. "Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder". Journal of urology. 1999; 162: 931 (#J0000365) |
| 102. | Schwartz EJ; Lepor H. "Radical retropubic prostatectomy reduces symptom scores and improves quality of life in men with moderate and severe lower urinary tract symptoms". Journal of urology. 1999; 161: 1185 (#J0002564) |
| 103. | Taneja SS; Penson DF; Epelbaum A; Handler T; Lepor H. "Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen". Journal of urology. 1999; 162: 1352 (#J0000396) |
| 104. | Walden PD; Gerardi C; Lepor H. "Localization and expression of the alpha1A-1, alpha1B and alpha1D-adrenoceptors in hyperplastic and non-hyperplastic human prostate". Journal of urology. 1999; 161: 635 (#J0002594) |
| 105. | Walden PD; Lefkowitz GK; Ittmann M; Lepor H; Monaco ME. "Mitogenic activation of human prostate-derived fibromuscular stromal cells by bradykinin". British journal of pharmacology. 1999; 127: 220 (#J0000281) |
| 106. | Lepor H; Williford WO; Barry MJ; Haakenson C; Jones K. "The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group". Journal of urology. 1998; 160: 1358 (#J0002940) |
| 107. | Lepor H. "Long-term evaluation of tamsulosin in benign prostatic hyperplasia: placebo-controlled, double-blind extension of phase III trial. Tamsulosin Investigator Group". Urology. 1998; 51: 901 (#J0009616) |
| 108. | Lepor H. "The pathophysiology of lower urinary tract symptoms in the ageing male population". British journal of urology. 1998; 81 Suppl 1: 29 (#J0104742) |
| 109. | Lepor H. "Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin Investigator Group". Urology. 1998; 51: 892 (#J0009617) |
| 110. | Lepor, H. "A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia - Comment". Journal of urology. 1998; 159: 1593 (#J0094557) |
| 111. | Lepor H; Chan S; Melamed J. "The role of bladder neck biopsy in men undergoing radical retropubic prostatectomy with preservation of the bladder neck". Journal of urology. 1998; 160: 2435 (#J0009506) |
| 112. | Lepor, H. "5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: A department of Veterans Affairs cooperative study - Editorial comments". Journal of urology. 1998; 160: 16 (#J0094323) |
| 113. | Levine MA; Ittman M; Melamed J; Lepor H. "Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer". Journal of urology. 1998; 159: 471 (#J0002943) |
| 114. | Obara K; Lepor H; Walden PD. "Localization of P2Y1 purinoceptor transcripts in the rat penis and urinary bladder". Journal of urology. 1998; 160: 587 (#J0003474) |
| 115. | Shapiro E; Seller MJ; Lepor H; Kalousek DK; Hutchins GM; Perlman EJ; Meuli M. "Altered smooth muscle development and innervation in the lower genitourinary and gastrointestinal tract of the male human fetus with myelomeningocele". Journal of urology. 1998; 160: 1047 (#J0009552) |
| 116. | Taneja, SS; Lepor, H. "Prostate specific antigen density of the transition zone for early detection of prostate cancer - Comment". Journal of urology. 1998; 160: 418 (#J0094197) |
| 117. | Walden PD; Ittmann M; Monaco ME; Lepor H. "Endothelin-1 production and agonist activities in cultured prostate-derived cells: implications for regulation of endothelin bioactivity and bioavailability in prostatic hyperplasia". Prostate. 1998; 34: 241 (#J0003240) |
| 118. | Walden PD; Lefkowitz GK; Ficazzola M; Gitlin J; Lepor H. "Identification of genes associated with stromal hyperplasia and glandular atrophy of the prostate by mRNA differential display". Experimental cell research. 1998; 245: 19 (#J0003241) |
| 119. | Wong WC; Chiu G; Wetzel JM; Marzabadi MR; Nagarathnam D; Wang D; Fang J; Miao SW; Hong X; Forray C; Vaysse PJ; Branchek TA; Gluchowski C; Tang R; Lepor H. "Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate". Journal of medicinal chemistry. 1998; 41: 2643 (#J0104835) |
| 120. | Andersson, KE; Lepor, H; Wyllie, MG. "Prostatic alpha(1)-adrenoceptors and uroselectivity". Prostate. 1997; 30: 202 (#J0093575) |
| 121. | Chun TY; Martin S; Lepor H. "Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy". Urology. 1997; 50: 727 (#J0009744) |
| 122. | Freedman, A L; Qureshi, F; Shapiro, E; Lepor, H; Jacques, S M; Evans, M I; Smith, C A; Gonzalez, R; Johnson, M P. "Smooth muscle development in the obstructed fetal bladder". Urology. 1997; 49: 104 (#J0154234) |
| 123. | Imajo C; Walden PD; Shapiro E; Doherty AM; Lepor H. "Evaluation of the effect of endothelin-1 and characterization of the selective endothelin a receptor antagonist PD155080 in the prostate". Journal of urology. 1997; 158: 253 (#J0002114) |
| 124. | Langenstroer, P; Tang, R; Divish, B; Opgenorth, T; Shapiro, E; Lepor, H. "Endothelins in canine genitourinary tissues". Journal of urology. 1997; 157: 1044 (#J0154233) |
| 125. | Lepor H; Nieder A; Feser J; O'Connell C; Dixon C. "Effect of terazosin on prostatism in men with normal and abnormal peak urinary flow rates". Urology. 1997; 49: 476 (#J0009994) |
| 126. | Lepor, H. "Terazosin, finasteride, or both in benign prostatic hyperplasia - Reply". New England journal of medicine. 1997; 336: 294 (#J0093831) |
| 127. | Lepor H; Nieder A; Feser J; O'Connell C; Dixon C. "Total prostate and transition zone volumes, and transition zone index are poorly correlated with objective measures of clinical benign prostatic hyperplasia [see comments]". Journal of urology. 1997; 158: 85 (#J0009908) |
| 128. | Shapiro E; Hartanto V; Perlman EJ; Tang R; Wang B; Lepor H. "Morphometric analysis of pediatric and nonhyperplastic prostate glands: evidence that BPH is not a unique stromal process". Prostate. 1997; 33: 177 (#J0009786) |
| 129. | Walden PD; Durkin MM; Lepor H; Wetzel JM; Gluchowski C; Gustafson EL. "Localization of mRNA and receptor binding sites for the alpha 1a-adrenoceptor subtype in the rat, monkey and human urinary bladder and prostate". Journal of urology. 1997; 157: 1032 (#J0010009) |
| 130. | Bystryn, Jean-Claude; Giangola, Gary; Lepor, Herbert; Lockwood, Charles; Siegel, Stephen. "Highlights of May 1996 - June 1996 television placements [videorecording]". 1996. 1996; (#B0001123) |
| 131. | Hatano A; Tang R; Walden PD; Lepor H. "The alpha-adrenoceptor antagonist properties of the enantiomers of doxazosin in the human prostate". European journal of pharmacology. 1996; 313: 135 (#J0010212) |
| 132. | Lepor H; Shapiro E; Wang B; Liang YC. "Comparison of the cellular composition of benign prostatic hyperplasia in Chinese and Caucasian-American men". Urology. 1996; 47: 38 (#J0104376) |
| 133. | Lepor H; Williford WO; Barry MJ; Brawer MK; Dixon CM; Gormley G; Haakenson C; Machi M; Narayan P; Padley RJ. "The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group". New England journal of medicine. 1996; 335: 533 (#J0104425) |
| 134. | Lepor, H. "Prostate selectivity of alpha-blockers: From receptor biology to clinical medicine". European urology. 1996; 29: 12 (#J0092922) |
| 135. | Lepor, H. "Transurethral microwave thermotherapy v sham treatment: Double-blind randomized study - Comment". Journal of endourology. 1996; 10: 573 (#J0093948) |
| 136. | Lepor, H; Nitti, VW. "Treatment of benign prostatic hyperplasia - Reply". Lancet. 1996; 347: 1270 (#J0092840) |
| 137. | McGrath, JC; Lepor, H; Wyllie, MG. "Report of a unique meeting between the alpha-blocker subcommittee and the pharmaceutical industry". Urology. 1996; 48: 665 (#J0092211) |
| 138. | BARRY, MJ; WILLIFORD, WO; CHANG, YC; MACHI, M; JONES, KM; WALKERCORKERY, E; LEPOR, H. "BENIGN PROSTATIC HYPERPLASIA SPECIFIC HEALTH-STATUS MEASURES IN CLINICAL RESEARCH - HOW MUCH CHANGE IN THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX AND THE BENIGN PROSTATIC HYPERPLASIA IMPACT INDEX IS PERCEPTIBLE TO PATIENTS". Journal of urology. 1995; 154: 1770 (#J0149025) |
| 139. | Burnett AL; Maguire MP; Chamness SL; Ricker DD; Takeda M; Lepor H; Chang TS. "Characterization and localization of nitric oxide synthase in the human prostate". Urology. 1995; 45: 435 (#J0104986) |
| 140. | LEPOR, H. "ALPHA-BLOCKADE FOR BENIGN PROSTATIC HYPERPLASIA (BPH)". Journal of clinical endocrinology & metabolism. 1995; 80: 750 (#J0151670) |
| 141. | Lepor H. "Alpha 1-adrenoceptor selectivity: clinical or theoretical benefit?". British journal of urology. 1995; 76 Suppl 1: 57 (#J0010645) |
| 142. | Lepor H. "Alpha blockade for the treatment of benign prostatic hyperplasia". Urologic clinics of North America. 1995; 22: 375 (#J0001229) |
| 143. | LEPOR, H. "BENIGN PROSTATIC HYPERPLASIA". Journal of urology. 1995; 153: 1540 (#J0151586) |
| 144. | Lepor H. "Combination medical therapy for benign prostatic hyperplasia". Urologic clinics of North America. 1995; 22: 401 (#J0010697) |
| 145. | LEPOR, H. "DOXAZOSIN IN TREATMENT OF BENIGN PROSTATIC HYPERPLASIA IN NORMOTENSIVE PATIENTS - MULTICENTER STUDY - COMMENT". Journal of urology. 1995; 154: 109 (#J0151345) |
| 146. | Lepor H; Tang R; Kobayashi S; Shapiro E; Forray C; Wetzel JM; Gluchowski C. "Localization of the alpha 1A-adrenoceptor in the human prostate". Journal of urology. 1995; 154: 2096 (#J0010551) |
| 147. | Lepor H. "Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasia. Terazosin Research Group". Urology. 1995; 45: 406 (#J0010737) |
| 148. | Lepor H; Theune C. "Randomized double-blind study comparing the efficacy of terazosin versus placebo in women with prostatism-like symptoms [see comments]". Journal of urology. 1995; 154: 116 (#J0010635) |
| 149. | Lepor H. "The treatment of benign prostatic hyperplasia: a glimpse into the future". Urologic clinics of North America. 1995; 22: 455 (#J0001230) |
| 150. | Lepor, Herbert. "Advances in benign prostatic hyperplasia". Philadelphia : W.B. Saunders, 1995. 1995; (#B0001084) |
| 151. | Nitti VW; Lepor H. "Urology. Controversies old and new [abstract]". Lancet. 1995; 346 Suppl: s26 (#J0009703) |
| 152. | Shapiro E; Lepor H. "Matrix changes in the bladder associated with normal aging". Advances in experimental medicine & biology. 1995; 385: 187 (#J0104394) |
| 153. | Shapiro E; Lepor H. "Pathophysiology of clinical benign prostatic hyperplasia". Urologic clinics of North America. 1995; 22: 285 (#J0001348) |
| 154. | Takeda M; Tang R; Shapiro E; Burnett AL; Lepor H. "Effects of nitric oxide on human and canine prostates". Urology. 1995; 45: 440 (#J0104339) |
| 155. | TAKEDA, M; LEPOR, H. "NITRIC-OXIDE SYNTHASE IN DOG URETHRA - A HISTOCHEMICAL AND PHARMACOLOGICAL ANALYSIS". British journal of pharmacology. 1995; 116: 2517 (#J0148952) |
| 156. | Forray, C; Bard, J A; Wetzel, J M; Chiu, G; Shapiro, E; Tang, R; Lepor, H; Hartig, P R; Weinshank, R L; Branchek, T A. "The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype". Molecular pharmacology. 1994; 45: 703 (#J0154236) |
| 157. | Kobayashi, S; Tang, R; Wang, B; Opgenorth, T; Langenstroer, P; Shapiro, E; Lepor, H. "Binding and functional properties of endothelin receptor subtypes in the human prostate". Molecular pharmacology. 1994; 45: 306 (#J0154238) |
| 158. | Kobayashi, S; Tang, R; Wang, B; Opgenorth, T; Stein, E; Shapiro, E; Lepor, H. "Localization of endothelin receptors in the human prostate". Journal of urology. 1994; 151: 763 (#J0154237) |
| 159. | Lepor H; Zhang W; Kobayashi S; Tang R; Wang B; Shapiro E. "A comparison of the binding and functional properties of alpha-1 adrenoceptors and area density of smooth muscle in the human, canine and rat prostates". Journal of pharmacology & experimental therapeutics. 1994; 270: 722 (#J0000823) |
| 160. | Lepor H; Owens RS; Rogenes V; Kuhn E. "Detection of prostate cancer in males with prostatism". Prostate. 1994; 25: 132 (#J0010922) |
| 161. | Lepor H; Guerena M; Dixon CM. "Perianastomotic injection of autologous fat at the time of radical retropubic prostatectomy". Urology. 1994; 44: 783 (#J0010848) |
| 162. | Lepor H; Shapiro E. "Prostatic alpha adrenoceptors". Progress in clinical & biological research. 1994; 386: 271 (#J0011169) |
| 163. | Lepor, H; Wang, B; Shapiro, E. "Relationship between prostatic epithelial volume and serum prostate-specific antigen levels". Urology. 1994; 44: 199 (#J0154235) |
| 164. | Shapiro E; Lepor H. "The pathophysiology of clinical BPH". Progress in clinical & biological research. 1994; 386: 253 (#J0011170) |
| 165. | TAKEDA, M; TANG, R; SHAPIRO, E; LEPOR, H; BURNETT, AL. "FUNCTIONAL-ACTIVITY OF NITRIC-OXIDE SYNTHASE (NOS) IN HUMAN AND CANINE PROSTATE [Abstract]". FASEB journal. 1994; 8: A362 (#J0091564) |
| 166. | TANG, R; LEPOR, H; SHAPIRO, E; FORRAY, C; WETZEL, J; GLUCHOWSKI, C. "LOCALIZATION OF ALPHA1C ADRENOCEPTORS (ALPHA-1C AR) IN THE HUMAN PROSTATIC TISSUE [Abstract]". FASEB journal. 1994; 8: A875 (#J0091541) |
| 167. | Kobayashi, S; Tang, R; Shapiro, E; Lepor, H. "Characterization and localization of prostatic alpha 1 adrenoceptors using radioligand receptor binding on slide-mounted tissue section". Journal of urology. 1993; 150: 2002 (#J0154239) |
| 168. | Langenstroer, P; Tang, R; Shapiro, E; Divish, B; Opgenorth, T; Lepor, H. "Endothelin-1 in the human prostate: tissue levels, source of production and isometric tension studies". Journal of urology. 1993; 150: 495 (#J0154240) |
| 169. | Lepor, H; Tang, R; Shapiro, E. "The alpha-adrenoceptor subtype mediating the tension of human prostatic smooth muscle". Prostate. 1993; 22: 301 (#J0154243) |
| 170. | Lepor, H; Tang, R; Meretyk, S; Shapiro, E. "Alpha 1 adrenoceptor subtypes in the human prostate". Journal of urology. 1993; 149: 640 (#J0154242) |
| 171. | Lepor, H; Tang, R; Meretyk, S; Shapiro, E. "Binding and functional properties of alpha1 adrenoceptors in different regions of the human prostate". Journal of urology. 1993; 150: 253 (#J0154241) |
| 172. | Lepor H. "Medical therapy for benign prostatic hyperplasia [see comments]". Urology. 1993; 42: 483 (#J0011205) |
| 173. | Lepor H; Tang R; Meretyk S; Hartanto V; Shapiro E. "Binding and functional properties of alpha 1 adrenoceptors and area density of smooth muscle in the canine prostate". Journal of urology. 1992; 148: 1310 (#J0020301) |
| 174. | Lepor H; Sunaryadi I; Hartanto V; Shapiro E. "Quantitative morphometry of the adult human bladder". Journal of urology. 1992; 148: 414 (#J0020302) |
| 175. | Meretyk, S; Tang, R; Shapiro, E; Kyncl, J J; Lepor, H. "Alpha 1-adrenoceptor properties of terazosin HCl and its enantiomers in the human prostate and canine brain". Prostate. 1992; 20: 159 (#J0154245) |
| 176. | Peters, C A; Vasavada, S; Dator, D; Carr, M; Shapiro, E; Lepor, H; McConnell, J; Retik, A B; Mandell, J. "The effect of obstruction on the developing bladder". Journal of urology. 1992; 148: 491 (#J0154244) |
| 177. | Shapiro E; Hartanto V; Lepor H. "Anti-desmin vs. anti-actin for quantifying the area density of prostate smooth muscle". Prostate. 1992; 20: 259 (#J0004188) |
| 178. | Shapiro E; Hartanto V; Lepor H. "Quantifying the smooth muscle content of the prostate using double-immunoenzymatic staining and color assisted image analysis". Journal of urology. 1992; 147: 1167 (#J0004189) |
| 179. | Shapiro E; Becich MJ; Hartanto V; Lepor H. "The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia". Journal of urology. 1992; 147: 1293 (#J0004475) |
| 180. | Shapiro E; Hartanto V; Lepor H. "The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle". Prostate. 1992; 21: 297 (#J0020303) |
| 181. | Lepor, H; Gup, D I; Baumann, M; Shapiro, E. "Comparison of alpha 1 adrenoceptors in the prostate capsule of men with symptomatic and asymptomatic benign prostatic hyperplasia". British journal of urology. 1991; 67: 493 (#J0154248) |
| 182. | Shapiro, E; Tang, R; Rosenthal, E; Lepor, H. "The binding and functional properties of voltage dependent calcium channel receptors in pediatric normal and myelodysplastic bladders". Journal of urology. 1991; 146: 520 (#J0154246) |
| 183. | Shapiro, E; Becich, M J; Perlman, E; Lepor, H. "Bladder wall abnormalities in myelodysplastic bladders: a computer assisted morphometric analysis". Journal of urology. 1991; 145: 1024 (#J0154247) |
| 184. | Gup, D I; Shapiro, E; Baumann, M; Lepor, H. "Autonomic receptors in human prostate adenomas". Journal of urology. 1990; 143: 179 (#J0154254) |
| 185. | Lepor, H; Baumann, M; Shapiro, E. "Binding and functional properties of doxazosin in the human prostate adenoma and canine brain". Prostate. 1990; 16: 29 (#J0154253) |
| 186. | Lepor, H; Shapiro, E; Bowsher, R R; Henry, D P. "Determination of norepinephrine levels in the adult human prostate". Journal of urology. 1990; 144: 1263 (#J0154250) |
| 187. | Lepor, H; Rigaud, G; Shapiro, E; Baumann, M; Kodner, I J; Fleshman, J W. "Muscarinic cholinergic and alpha 2-adrenergic receptors in the epithelium and muscularis of the human ileum". Surgery. 1990; 107: 461 (#J0154251) |
| 188. | Lepor, H; Shapiro, E. "This month in investigative urology: alpha adrenergic innervation of the prostate: insights into pharmacotherapy of BPH". Journal of urology. 1990; 143: 590 (#J0154252) |
| 189. | Rosenthal, E; Shapiro, E; Lepor, H. "Characterization of 1,4, dihydropyridine calcium channel binding sites in the human prostate". Journal of urology. 1990; 144: 1539 (#J0154249) |
| 190. | Gup, D I; Shapiro, E; Baumann, M; Lepor, H. "Contractile properties of human prostate adenomas and the development of infravesical obstruction". Prostate. 1989; 15: 105 (#J0154258) |
| 191. | Gup, D I; Baumann, M; Lepor, H; Shapiro, E. "Muscarinic cholinergic receptors in normal pediatric and myelodysplastic bladders". Journal of urology. 1989; 142: 595 (#J0154256) |
| 192. | Lepor, H; Mohler, J; Baumann, M; Shapiro, E. "Comparison of muscarinic cholinergic and alpha adrenergic receptors in canine ileum, colon, intestinal urinary reservoirs and bladder". Journal of urology. 1989; 142: 204 (#J0154257) |
| 193. | Lepor, H; Gup, D; Shapiro, E; Baumann, M. "Muscarinic cholinergic receptors in the normal and neurogenic human bladder". Journal of urology. 1989; 142: 869 (#J0154255) |
| 194. | Lepor, H; Baumann, M; Shapiro, E. "The alpha adrenergic binding properties of terazosin in the human prostate adenoma and canine brain". Journal of urology. 1988; 140: 664 (#J0154262) |
| 195. | Lepor, H; Shapiro, E; Gup, D; Baumann, M. "The effect of electrocautery on neurotransmitter receptor binding assays in the canine prostate". Journal of urology. 1988; 140: 668 (#J0154261) |
| 196. | Lepor, H; Gup, D I; Baumann, M; Shapiro, E. "Laboratory assessment of terazosin and alpha-1 blockade in prostatic hyperplasia". Urology. 1988; 32: 21 (#J0154259) |
| 197. | Lepor, H; Baumann, M; Shapiro, E. "The stereospecificity of LY253352 for alpha 1-adrenoceptor binding sites in the brain and prostate". British journal of pharmacology. 1988; 95: 139 (#J0154260) |
| 198. | Lepor, H; Baumann, M; Shapiro, E. "Identification and characterization of alpha 1 adrenergic receptors in the canine prostate using [125I]-Heat". Journal of urology. 1987; 138: 1336 (#J0154263) |
| 199. | Shapiro, E; Tsitlik, J E; Lepor, H. "Alpha 2 adrenergic receptors in canine prostate: biochemical and functional correlations". Journal of urology. 1987; 137: 565 (#J0154265) |
| 200. | Shapiro, E; Lepor, H. "Alpha 1 adrenergic receptors in canine lower genitourinary tissues: insight into development and function". Journal of urology. 1987; 138: 979 (#J0154264) |
| 201. | Shapiro, E; Lepor, H. "Alpha 2 adrenergic receptors in hyperplastic human prostate: identification and characterization using [3H] rauwolscine". Journal of urology. 1986; 135: 1038 (#J0154266) |
| 202. | Shapiro, E; Miller, A R; Lepor, H. "Down regulation of the muscarinic cholinergic receptor of the rat prostate following castration". Journal of urology. 1985; 134: 179 (#J0154268) |
| 203. | Shapiro, E; Jeffs, R D; Gearhart, J P; Lepor, H. "Muscarinic cholinergic receptors in bladder exstrophy: insights into surgical management". Journal of urology. 1985; 134: 308 (#J0154267) |
| 204. | Lepor, H; Shapiro, E. "Characterization of alpha1 adrenergic receptors in human benign prostatic hyperplasia". Journal of urology. 1984; 132: 1226 (#J0154269) |
| 205. | Lepor, H; Shapiro, E; Jeffs, R D. "Urethral reconstruction in boys with classical bladder exstrophy". Journal of urology. 1984; 131: 512 (#J0154271) |
| 206. | Shapiro, E; Lepor, H; Jeffs, R D. "The inheritance of the exstrophy-epispadias complex". Journal of urology. 1984; 132: 308 (#J0154270) |
All data from NYU School of Medicine Ehrman Medical Library Faculty Bibliography
NYU Faculty may edit their publications and access other personalized services at http://myinfo.med.nyu.edu
For more information contact: facbib@library.med.nyu.edu
or see: http://library.med.nyu.edu/library/eresources/faculty/bib-faq.html
